The effectiveness of Cholestimide on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Trial Profile

The effectiveness of Cholestimide on dyslipidemia with visceral fat accumulation in patients with type 2 diabetes. A randomized parallel crossover trial

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 May 2016

At a glance

  • Drugs Colestilan (Primary) ; HMG-CoA reductase inhibitors
  • Indications Dyslipidaemias
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Jan 2014 According to University Hospital Medical Information Network - Japan record, status changed from active, no longer recruiting to completed.
    • 21 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top